RE: capital reduction2 Nov 2020 11:41
The company has previously stated that no value with the TILS share price had been attributed to Accustem, thus the spin-out. If this is the case, then can we not (despite the contradictory drop in SP) argue that Accustem should in fact, have no effect on the market price off TILS and yet, here we are.